EX02 CAR-T Cells for Relapsed and Refractory Acute Myeloid Leukemia

Clinical trial NCT06642025 · RECRUITING

Trial details

NCT number: NCT06642025
Sponsor: Zhimin Zhai
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukemia (AML)CAR-T

Start date: 2024-09-01
Primary completion: 2026-08-01
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.